PRNewsWire · ABT · November 1, 2026

Abbott's TECTONIC clinical trial demonstrates strong 30-day outcomes and high procedural success for its investigational SonicForce™ Coronary Intravascular Lithotripsy System

Get the app for more

Explore stock news, insights and company research.